Acknowledgement
This research was financially supported by FrontBio Inc. and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2021R1A6A1A03044501).
References
- Negre-Salvayre A, Salvayre R, Auge N, Pamplona R, Portero-Otin M. Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal 2009;11:3071-109. https://doi.org/10.1089/ars.2009.2484
- Gilbert MP. Screening and treatment by the primary care provider of common diabetes complications. Med Clin North Am 2015;99:201-19. https://doi.org/10.1016/j.mcna.2014.09.002
- Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T. Macrovascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol 2020;18:110-6. https://doi.org/10.2174/1570161117666190405165151
- Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol 2020;16:377-90. https://doi.org/10.1038/s41581-020-0278-5
- Park S, Kang HJ, Jeon JH, Kim MJ, Lee IK. Recent advances in the pathogenesis of microvascular complications in diabetes. Arch Pharm Res 2019;42:252-62. https://doi.org/10.1007/s12272-019-01130-3
- Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005;28:164-76. https://doi.org/10.2337/diacare.28.1.164
- Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010;376:124-36. https://doi.org/10.1016/S0140-6736(09)62124-3
- Adki KM, Kulkarni YA. Potential biomarkers in diabetic retinopathy. Curr Diabetes Rev 2020;16:971-83. https://doi.org/10.2174/1573399816666200217092022
- Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V. Diabetic neuropathy. Nat Rev Dis Primers 2019;5:41.
- Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol 2007;27:195-207. https://doi.org/10.1016/j.semnephrol.2007.01.012
- Menon MC, Chuang PY, He CJ. The glomerular filtration barrier: components and crosstalk. Int J Nephrol 2012;2012:749010.
- Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int 2008;74:22-36. https://doi.org/10.1038/ki.2008.128
- Gorriz JL, Martinez-Castelao A. Proteinuria: detection and role in native renal disease progression. Transplant Rev (Orlando) 2012;26:3-13. https://doi.org/10.1016/j.trre.2011.10.002
- Kanasaki K, Taduri G, Koya D. Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis. Front Endocrinol (Lausanne) 2013;4:7.
- Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011;7:684-96. https://doi.org/10.1038/nrneph.2011.149
- Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest 2014;124:2299-306. https://doi.org/10.1172/JCI72267
- Arboleda-Velasquez JF, Valdez CN, Marko CK, D'Amore PA. From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathy. Curr Diab Rep 2015;15:573.
- Wong TY, Cheung CM, Larsen M, Sharma S, Simo R. Diabetic retinopathy. Nat Rev Dis Primers 2016;2:16012.
- Al-Latayfeh M, Silva PS, Sun JK, Aiello LP. Antiangiogenic therapy for ischemic retinopathies. Cold Spring Harb Perspect Med 2012;2:a006411.
- Campochiaro PA. Molecular pathogenesis of retinal and choroidal vascular diseases. Prog Retin Eye Res 2015;49:67-81. https://doi.org/10.1016/j.preteyeres.2015.06.002
- Boyer DS, Hopkins JJ, Sorof J, Ehrlich JS. Anti-vascular endothelial growth factor therapy for diabetic macular edema. Ther Adv Endocrinol Metab 2013;4:151-69. https://doi.org/10.1177/2042018813512360
- Zheng HX, Qi SS, He J, Hu CY, Han H, Jiang H, Li XS. Cyanidin-3-glucoside from black rice ameliorates diabetic nephropathy via reducing blood glucose, suppressing oxidative stress and inflammation, and regulating transforming growth factor β1/Smad expression. J Agric Food Chem 2020;68:4399-410. https://doi.org/10.1021/acs.jafc.0c00680
- Kang MK, Park SH, Choi YJ, Shin D, Kang YH. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition. J Mol Med (Berl) 2015;93:759-72. https://doi.org/10.1007/s00109-015-1301-3
- Kang MK, Park SH, Kim YH, Lee EJ, Antika LD, Kim DY, Choi YJ, Kang YH. Dietary compound chrysin inhibits retinal neovascularization with abnormal capillaries in db/db mice. Nutrients 2016;8:782.
- Zhou L, Zhang P, Yang G, Lin R, Wang W, Liu T, Zhang L, Zhang J. Solubility of chrysin in ethanol and water mixtures. J Chem Eng Data 2014;59:2215-20. https://doi.org/10.1021/je5001654
- Hwang SH, Kim HY, Zuo G, Wang Z, Lee JY, Lim SS. Anti-glycation, carbonyl trapping and antiinflammatory activities of chrysin derivatives. Molecules 2018;23:1752.
- Zhang A, Huang S. Progress in pathogenesis of proteinuria. Int J Nephrol 2012;2012:314251.
- Zoja C, Abbate M, Remuzzi G. Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration. Nephrol Dial Transplant 2015;30:706-12. https://doi.org/10.1093/ndt/gfu261
- Capitao M, Soares R. Angiogenesis and inflammation crosstalk in diabetic retinopathy. J Cell Biochem 2016;117:2443-53. https://doi.org/10.1002/jcb.25575
- Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A. Pathophysiology of diabetic retinopathy: the old and the new. Diabetes Metab J 2018;42:364-76. https://doi.org/10.4093/dmj.2018.0182
- Bhatti JS, Sehrawat A, Mishra J, Sidhu IS, Navik U, Khullar N, Kumar S, Bhatti GK, Reddy PH. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives. Free Radic Biol Med 2022;184:114-34. https://doi.org/10.1016/j.freeradbiomed.2022.03.019
- Zheng S, Huang K, Tong T. Efficacy and mechanisms of oleuropein in mitigating diabetes and diabetes complications. J Agric Food Chem 2021;69:6145-55. https://doi.org/10.1021/acs.jafc.1c01404
- Oliveira S, Monteiro-Alfredo T, Silva S, Matafome P. Curcumin derivatives for type 2 diabetes management and prevention of complications. Arch Pharm Res 2020;43:567-81. https://doi.org/10.1007/s12272-020-01240-3
- Khan M, Liu H, Wang J, Sun B. Inhibitory effect of phenolic compounds and plant extracts on the formation of advance glycation end products: a comprehensive review. Food Res Int 2020;130:108933.
- Rodriguez ML, Perez S, Mena-Molla S, Desco MC, Ortega AL. Oxidative stress and microvascular alterations in diabetic retinopathy: future therapies. Oxid Med Cell Longev 2019;2019:4940825.
- Gowd V, Kang Q, Wang Q, Wang Q, Chen F, Cheng KW. Resveratrol: evidence for its nephroprotective effect in diabetic nephropathy. Adv Nutr 2020;11:1555-68. https://doi.org/10.1093/advances/nmaa075
- Catrina SB, Zheng X. Hypoxia and hypoxia-inducible factors in diabetes and its complications. Diabetologia 2021;64:709-16. https://doi.org/10.1007/s00125-021-05380-z
- Lee EJ, Kang MK, Kim DY, Kim YH, Oh H, Kang YH. Chrysin inhibits advanced glycation end products-induced kidney fibrosis in renal mesangial cells and diabetic kidneys. Nutrients 2018;10:882. https://doi.org/10.3390/nu10070882
- Ravindran S, Munusamy S. Renoprotective mechanisms of sodium-glucose co-transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease. J Cell Physiol 2022;237:1182-205. https://doi.org/10.1002/jcp.30621
- Alicic RZ, Cox EJ, Neumiller JJ, Tuttle KR. Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence. Nat Rev Nephrol 2021;17:227-44. https://doi.org/10.1038/s41581-020-00367-2
- Abbate M, Zoja C, Corna D, Rottoli D, Zanchi C, Azzollini N, Tomasoni S, Berlingeri S, Noris M, Morigi M, et al. Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. J Am Soc Nephrol 2008;19:1158-67. https://doi.org/10.1681/ASN.2007060686
- Osaadon P, Fagan XJ, Lifshitz T, Levy J. A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond) 2014;28:510-20. https://doi.org/10.1038/eye.2014.13
- Tan Y, Fukutomi A, Sun MT, Durkin S, Gilhotra J, Chan WO. Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: a review. Surv Ophthalmol 2021;66:926-32. https://doi.org/10.1016/j.survophthal.2021.03.001
- Sulaiman RS, Basavarajappa HD, Corson TW. Natural product inhibitors of ocular angiogenesis. Exp Eye Res 2014;129:161-71. https://doi.org/10.1016/j.exer.2014.10.002
- Stompor-Goracy M, Bajek-Bil A, Machaczka M. Chrysin: perspectives on contemporary status and future possibilities as pro-health agent. Nutrients 2021;13:2038.
- Zhu ZY, Wang WX, Wang ZQ, Chen LJ, Zhang JY, Liu XC, Wu SP, Zhang YM. Synthesis and antitumor activity evaluation of chrysin derivatives. Eur J Med Chem 2014;75:297-300. https://doi.org/10.1016/j.ejmech.2013.12.044